<DOC>
	<DOCNO>NCT01976299</DOCNO>
	<brief_summary>The Osprey Medical AVERT System indicate reduce contrast medium ( CM ) exposure kidney percutaneous coronary procedure thereby reduce risk contrast induce nephropathy ( CIN ) .</brief_summary>
	<brief_title>AVERTâ„¢ Clinical Trial Contrast Media Volume Reduction Incidence CIN</brief_title>
	<detailed_description>The purpose trial ass AVERT System device , design limit volume CM ( Contrast Media ) utilize , stag therapeutic coronary PCI ( Percutaneous Coronary Intervention ) coronary diagnostic procedure anticipate become PCI ( i.e . ad hoc PCI ) reduction CIN ( Contrast Induced Nephropathy ) .</detailed_description>
	<criteria>The subject candidate therapeutic percutaneous coronary intervention ( PCI ) procedure . The subject document chronic kidney disease ( CKD ) Subject acute renal failure Assessment ventricular function accomplish without use CM . Subject acute STEMI within 72 hour prior plan PCI procedure , currently acute STEMI . Subject unable undergo periprocedural hydration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>